Effect Of Berberine Administration On Metabolic Syndrome, Insulin Sensitivity, And Insulin Secretion
| Effect | Decrease |
| Values | Decrease in systolic only after 3 months: 123mmHg in placebo versus 115±9 mmHg with berberine. |
| Trial Design | Randomized trial |
| Trial Length | 1-6 months |
| Number of Subjects | 24 |
| Sex | Both Genders |
| Body Types | Obese, Overweight |
24 people with metabolic syndrome were randomized to placebo or 0.5g berberine three times a day for three months. Decrease in waist circumference in females only, systolic blood pressure, triglycerides, area under the curve of glucose and insulin, and Matsuda index were all seen to be significant in the berberine group versus placebo.
